Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Wounds : a Compendium of Clinical Research and Practice|July 17, 2025
Use of polyhexamethylene biguanide in the treatment of atopic dermatitis with Staphylococcus aureus hypercolonizationGleice Freire, Leticia Midori Kondo Iwamoto, Tatiana de Fátima Pinto, et al.
Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|June 24, 2026
[Migration of Primarily Metallic Elements from Commercial Paper and Bamboo Straws]Koji Fujihara, Midori Kondo, Eri Kishi, et al.
Shokuhin Eiseigaku Zasshi. Journal of the Food Hygienic Society of Japan|September 6, 2023
[Development of Analytical Method and Surveillance ofGibberellic Acid in Banana, Cherry, and Kiwi Fruit]Yuki Yamasaki, Yoshinari Suzuki, Ikuko Kitayama, et al.
JAMA|April 3, 2002
Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapyMitchell K Higashi, David L Veenstra, L Midori Kondo, et al.
Annals of Surgical Treatment and Research|August 26, 2022
Preoperative lymphocyte-to-C-reactive protein ratio predicts hepatocellular carcinoma recurrence after surgeryMasashi Utsumi, Masaru Inagaki, Koji Kitada, et al.
Medicine|June 2, 2023
Preoperative C-reactive protein-to-albumin ratio as a prognostic factor in biliary tract cancer: A systematic review and meta-analysisMasashi Utsumi, Masaru Inagaki, Koji Kitada, et al.
Anticancer Research|October 3, 2022
Lymphocyte-to-C-Reactive Protein Ratio Predicts Prognosis in Patients With Colorectal Liver Metastases Post-hepatic Resection: A Retrospective StudyMasashi Utsumi, Masaru Inagaki, Koji Kitada, et al.
Scientific Reports|June 20, 2026
Clinical benefit of palbociclib retreatment after abemaciclib exposure in hormone receptor positive, HER2 negative metastatic breast cancerMuhan Yu, Michiko Yamashita, Mamoru Takada, et al.
International Journal of Hematology|July 4, 2008
A safety, pharmacokinetic and pharmacodynamic investigation of deferasirox (Exjade, ICL670) in patients with transfusion-dependent anemias and iron-overload: a Phase I study in JapanKeisuke Miyazawa, Kazuma Ohyashiki, Akio Urabe, et al.
Leukemia Research|October 26, 2016
Switching to nilotinib in patients with chronic myeloid leukemia in chronic phase with molecular suboptimal response to frontline imatinib: SENSOR final results and BIM polymorphism substudyKoichi Miyamura, Toshihiro Miyamoto, Mitsune Tanimoto, et al.
Pageof 3